Elicio Therapeutics (ELTX) S-4/A 2022 FY Registration of securities issued in business combination transactions (amended)

Exhibit 99.4

DIRECTOR CONSENT

I hereby consent to serve as a director of Angion Biomedica Corp. (the “Company”), if elected as such, and to be named as a nominee or potential nominee for director of the Company in any registration statement filed by the Company under the Securities Act of 1933, as amended, including all amendments and post-effective amendments or supplements thereto and any prospectus and/or proxy statement contained therein.

/s/ Daphne Karydas
Name:	Daphne Karydas
Date:	March 29, 2023